Pruritus is a common symptom seen in numerous situations. It may occur sporadically, for example after an insect bite, or persist in a chronic context, such as in the case of eczema. These itching sensations, often trivialized, nonetheless impair quality of life and reflect inflammatory and oxidative imbalances in the skin.
In this context, L-carnitine has demonstrated anti-inflammatory and anti-pruritic properties of interest. An experimental study evaluated its effects in a mouse model of chloroquine-induced itch. The results showed that oral administration of L-carnitine significantly reduced scratching behavior compared to the control group, confirming its antipruritic potential. On a biological level, the molecule restored the balance of antioxidant defenses (GST, GSH, and catalase) while reducing lipid peroxidation (LPO). It also decreased nitric oxide synthase (NOS) activity, thus modulating the nitric oxide pathway involved in itch genesis. Finally, L-carnitine reduced levels of pro-inflammatory cytokines (TNF-α), pro-inflammatory enzymes such as COX-2, and the p-NFκB marker. Together, these effects suggest that L-carnitine acts both by limiting inflammation and by regulating oxidative stress, thereby contributing to itch relief.
However, caution is warranted, as this study was conducted in mice and relied on oral administration of L-carnitine, which limits extrapolation.
Moreover, other studies have reported an interest in the L-carnitine in topical application to soothe eczema, but these studies combined the molecule with other actives whose efficacy against eczema is already well documented. It therefore remains difficult to determine to what extent L-carnitine alone truly contributes to symptom improvement.